1. Sage Therapeutics Reports Results of SAGE-217 in P-III MOUNTAIN Study for Major Depressive Disorders Published: Dec 05, 2019 | Tags: Sage Therapeutics,
[Read More...]
Shots: Seattle Genetics and Astellas sign a clinical trial agreement with Merck to evaluate the combination of Seattle Genetics’ and Astellas’ ADC and
[Read More...]
Shots: The approval is based on P-III Asian PREVAIL study assessing Xtandi (160mg/day) vs PBO + GnRH therapy or after bilateral orchiectomy in
[Read More...]
1. Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India Published: Nov 22, 2019 | Tags: Lupin,
[Read More...]
Shots: Welldoc to receive $15M upfront, development & commercialization milestones and royalties on sales. Astellas and Welldoc will jointly develop and commercialize BlueStar
[Read More...]
Shots: Pandion to receive up to $45M as upfront and payments for research and preclinical activities, ~$750M as development and commercial milestone and
[Read More...]
Shots: The US FDA has granted FT designation to the development of ASP1128 for patients at increased risk of developing moderate to severe
[Read More...]
1. Urology San Antonio Collaborates with Anixa Biosciences on Ccheck Prostate Cancer Study Published: Oct 25, 2019 | Tags: Urology San Antonio, Collaborates, Anixa
[Read More...]